Director Rick Orman resigns; CannaPharmaRX exports 250 kg to Israel, plans Q1 shipments and expansion

CANNAPHARMARX, INC.

Director Rick Orman resigned from board effective Jan 8, 2026; no dispute with company.
Exported 250 kg (6 batches) to Israel in Q4; three additional shipments scheduled Q1 2026.
New high-THC strains (Black Candyland, Goat Gas, Caligrape, Lemon Margy, Sour Chillz, Mac & Cheese) for German medical market.
Plans to raise capital, build 4 cultivation rooms, drying room, and EU-GMP processing area in 2026.
British Columbia Securities Commission cease trade order revoked effective December 12, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.